Repurposing HIV Protease Inhibitors against West Nile Virus: Insights from Molecular Docking and Molecular Dynamics Simulations
Renato D. dos Santos, Guilherme Colherinhas, Wesley B. Cardoso · 2026
Read Repurposing HIV Protease Inhibitors against West Nile Virus: Insights from Molecular Docking and Molecular Dynamics Simulations by Renato D. dos Santos, Guilherme Colherinhas, Wesley B. Cardoso (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13614167.txt.
Description
Renato D. dos Santos, Guilherme Colherinhas, and Wesley B. Cardoso test in 2026 whether HIV drugs could be reused against West Nile virus, a mosquito-borne virus that can attack the brain and has no approved drug treatment. Working fully on computers, they docked ten HIV protease blockers into the virus's own protease, an enzyme it needs to copy itself, then ran motion simulations to see which drugs stayed bound.
Two drugs, indinavir and atazanavir, held on firmly, with steady contact, lasting hydrogen bonds, and favourable binding energy. Several others scored well in the still docking test yet drifted loose once the simulation moved. The lesson for drug hunting is plain: a good first fit means little until the pairing survives motion. The two winners now merit testing in real lab experiments.
Catalog record
| CREATOR | Renato D. dos Santos, Guilherme Colherinhas, Wesley B. Cardoso |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39610 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |